Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 6775
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 280X1(4X70)
0167147 EU/1/09/574/011 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/12,5MG TBL FLM 280(20X14)
0167148 EU/1/09/574/012 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 14
0167149 EU/1/09/574/013 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 28
0167150 EU/1/09/574/014 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 30
0167151 EU/1/09/574/015 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 56
0167152 EU/1/09/574/016 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 90
0167153 EU/1/09/574/017 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 98
0167154 EU/1/09/574/018 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 280
0167155 EU/1/09/574/019 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 56X1
0167156 EU/1/09/574/020 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 98X1
0167157 EU/1/09/574/021 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 280X1
0167158 EU/1/09/574/022 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 280X1(4X70)
0167159 EU/1/09/574/023 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 10MG/160MG/12,5MG TBL FLM 280(20X14)
0167160 EU/1/09/574/024 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/25MG TBL FLM 14
0167161 EU/1/09/574/025 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/25MG TBL FLM 28
0167162 EU/1/09/574/026 dafirohct.pdf dafirohct.pdf C09DX01 R
DAFIRO HCT 5MG/160MG/25MG TBL FLM 30
0167163 EU/1/09/574/027 dafirohct.pdf dafirohct.pdf C09DX01 R
DAPRIL 5MG TBL NOB 30
0067561 58/ 912/95-A/C dapril.pdf dapril.pdf C09AA03 R
DAPRIL 10MG TBL NOB 30
0067562 58/ 912/95-B/C dapril.pdf dapril.pdf C09AA03 R
DAPRIL 20MG TBL NOB 60
0032505 58/ 912/95-C/C dapril.pdf dapril.pdf C09AA03 R

‹‹ ‹ 30 40 50 60 70 75 76 77 78 79 80 81 82 83 84 85 90 100 110 120 130 200 300 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 20. October 2020 at 01:08
Last update of price and payment data: 1. October 2020 at 01:09